EUVIMEDEUVIMED entdecken
Open Access

Clonal hematopoiesis of indeterminate potential and incidence of venous thromboembolism in older adults

Seyedmohammad Saadatagah, Rock Bum Kim, Senthil Sukumar, Md Mesbah Uddin, Aaron R Folsom, Mary Cushman, Weihong Tang, Pradeep Natarajan, Christie M Ballantyne, Pamela L Lutsey, Ang Li

Journal of Thrombosis and Haemostasis · 2025-07 · 23 (7) · 2235-2241

DOI: 10.1016/j.jtha.2025.03.042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025-07. Verfasst von Seyedmohammad Saadatagah und 10 weiteren Autor:innen. Beteiligte Einrichtung: Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA; Center for Translational Research on Inflammatory Dis…. Hauptthemen laut MEDLINE: Clonal Hematopoiesis, Venous Thromboembolism. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCI NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Clonal hematopoiesis of indeterminate potential (CHIP) is associated with an increased risk of cardiovascular diseases, but its association with venous thromboembolic events (VTE) is unclear. OBJECTIVES: We investigated the association between CHIP and incident VTE in older adults and evaluated whether risk varies by CHIP driver gene. METHODS: Participants from the community-based Atherosclerosis Risk in Communities Study without a history of VTE or hematologic malignancies were included. Whole-exome sequencing from peripheral blood was used to ascertain CHIP (variant allele frequency ≥ 2%) and common gene-specific CHIP subtypes (DNMT3A, TET2, and ASXL1). The primary outcome was incident VTE (adjudicated by experts from medical record review), defined as symptomatic and asymptomatic pulmonary embolism and lower extremity deep vein thrombosis. Multivariable Cox proportional hazard models were used to study the association between CHIP and VTE. RESULTS: Of 3980 participants included (median [25th-75th percentiles] age, 75.0 [71.0-79.0] years), 2359 (59.3%) were female, 1621 (40.7%) were male, 890 (22.4%) identified as Black, and 3090 (77.6%) identified as White; 985 (24.7%) had CHIP. Over a median 7.1-year follow-up, VTE occurred in 44 (4.5%) CHIP carriers vs 96 (3.2%) noncarriers (hazard ratio, 1.49; 95% CI, 1.02-2.17; P = .038). TET2 mutation was significantly associated with VTE risk (hazard ratio, 2.25; 95% CI, 1.27-4.00; P = .006). CONCLUSION: In this cohort study of older adults, we identified a modestly increased risk of VTE in individuals with CHIP, mainly driven by TET2 mutation. Future research should explore the mechanisms driving these associations and assess potential therapeutic and preventive strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clonal HematopoiesisVenous ThromboembolismHumansFemaleMaleAgedDioxygenasesIncidenceRisk FactorsProto-Oncogene ProteinsDNA-Binding ProteinsGenetic Predisposition to DiseaseAge FactorsDNA Methyltransferase 3ARepressor ProteinsUnited StatesExome SequencingRisk AssessmentDNA (Cytosine-5-)-MethyltransferasesMutation

Stichwörter der Autor:innen

clonal hematopoiesisepidemiologyvenous thromboembolism

Substanzen

TET2 protein, humanDioxygenasesProto-Oncogene ProteinsDNA-Binding ProteinsASXL1 protein, humanDNA Methyltransferase 3ADNMT3A protein, humanRepressor ProteinsDNA (Cytosine-5-)-Methyltransferases

Autor:innen und Institutionen

  • Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA; Center for Translational Research on Inflammatory Diseases, Baylor College of Medicine, Houston, Texas, USA.
  • Section of Hematology-Oncology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
  • Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA; Program in Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of Harvard and Massachusetts…
  • Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.
  • Department of Medicine, Larner College of Medicine at the University of Vermont, Burlington, Vermont, USA.
  • Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.

Förderung

  • NHLBI NIH HHS
  • NCI NIH HHS
  • NIH HHS
  • NIH
  • ASH Foundation
  • National Heart, Lung, and Blood Institute
  • American Society of Hematology
  • U.S. Department of Health and Human Services

Zitieren

APA

Saadatagah, S., Kim, R. B., Sukumar, S., Uddin, M. M., Folsom, A. R., Cushman, M., Tang, W., Natarajan, P., Ballantyne, C. M., Lutsey, P. L., & Li, A. (2025). Clonal hematopoiesis of indeterminate potential and incidence of venous thromboembolism in older adults. Journal of Thrombosis and Haemostasis, 23(7), 2235-2241. https://doi.org/10.1016/j.jtha.2025.03.042

Vancouver

Saadatagah S, Kim RB, Sukumar S, Uddin MM, Folsom AR, Cushman M, et al. Clonal hematopoiesis of indeterminate potential and incidence of venous thromboembolism in older adults. Journal of Thrombosis and Haemostasis. 2025;23(7):2235-2241. doi:10.1016/j.jtha.2025.03.042

BibTeX
@article{Saadatagah2025,
  author = {Saadatagah, Seyedmohammad and Kim, Rock Bum and Sukumar, Senthil and Uddin, Md Mesbah and Folsom, Aaron R and Cushman, Mary and Tang, Weihong and Natarajan, Pradeep and Ballantyne, Christie M and Lutsey, Pamela L and Li, Ang},
  title = {Clonal hematopoiesis of indeterminate potential and incidence of venous thromboembolism in older adults},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2025},
  volume = {23},
  number = {7},
  pages = {2235--2241},
  doi = {10.1016/j.jtha.2025.03.042}
}
Kostenlos starten →